Vertex Pharmaceuticals Income Taxes Paid, Net decreased by 78.9% to $82.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 55.4%, from $184.40M to $82.30M. Over 4 years (FY 2021 to FY 2025), Income Taxes Paid, Net shows an upward trend with a 34.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A lower cash tax rate relative to statutory rates can indicate effective tax planning, while high cash taxes may signal a lack of tax-efficient strategies or one-time tax events.
This metric represents the actual cash paid for income taxes during the period, net of any refunds received. It provides...
Standard supplemental disclosure; peers are compared based on their cash effective tax rate.
supplemental_income_taxes_paid_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $223.70M | $147.10M | $94.80M | $85.00M | $393.30M | $361.80M | $217.70M | $120.30M | $498.40M | $300.40M | $758.20M | $34.80M | $497.00M | $278.50M | $271.80M | $184.40M | $513.30M | $479.60M | $389.40M | $82.30M |
| QoQ Change | — | -34.2% | -35.6% | -10.3% | +362.7% | -8.0% | -39.8% | -44.7% | +314.3% | -39.7% | +152.4% | -95.4% | >999% | -44.0% | -2.4% | -32.2% | +178.4% | -6.6% | -18.8% | -78.9% |
| YoY Change | — | — | — | — | +75.8% | +146.0% | +129.6% | +41.5% | +26.7% | -17.0% | +248.3% | -71.1% | -0.3% | -7.3% | -64.2% | +429.9% | +3.3% | +72.2% | +43.3% | -55.4% |